The Impact of Racial and Ethnic Health Disparities in Diabetes Management on Clinical Outcomes: A Reinforcement Learning Analysis of Health Inequity Among Youth and Young Adults in the SEARCH for Diabetes in Youth Study
<a><b>Objective: </b></a>To estimate difference in population-level glycemic control and the emergence of diabetes complications given a theoretical scenario whereby non-White youth and young adults (YYA) with type 1 diabetes (T1D) receive and follow an equivalent distribution of diabetes treatment regimens as non-Hispanic White YYA. <p><b>Research Design and Methods:</b> Longitudinal data from YYA diagnosed 2002-2005 in the SEARCH for Diabetes in Youth Study were analyzed. Based on self-reported race/ethnicity, YYA were classified as non-White race or Hispanic ethnicity (non-White subgroup) versus non-Hispanic White race (White subgroup). <a>In the White versus non-White subgroups, propensity scores model estimated treatment regimens, including patterns of insulin modality, self-monitored glucose frequency, and continuous glucose monitoring use.</a> An analysis based on policy evaluation technique in reinforcement learning estimated the effect of each treatment regimen on hemoglobin A1c (HbA1c) and diabetes complications for non-White YYA. </p> <p><b>Results: </b>The study included n=978 YYA. The sample was 47.5% female and77.5% non-Hispanic White, with mean age 12.8±2.4 years at diagnosis. The estimated population mean of longitudinal average HbA1c over visits was 9.2% and 8.2% for the non-White and White subgroup, respectively (difference=0.9%). Within the non-White subgroup, mean HbA1c across visits was estimated to decrease by 0.33% (95%CI: -0.45%, -0.21%) if these YYA received the distribution of diabetes treatment regimens of the White subgroup, explaining approximately 35% of the estimated difference between the two subgroups. The non-White subgroup was also estimated to have a lower risk of developing diabetic retinopathy, diabetic kidney disease, and peripheral neuropathy with the White youth treatment regimen distribution (p<0.05), although the low proportion of YYA who developed complications limited statistical power for risk estimations.</p> <p><b>Conclusions: </b>Mathematically modeling an equalized distribution of T1D self-management tools and technology accounted for part but not all disparities in glycemic control between non-White and White YYA, underscoring the complexity of race/ethnicity-based health inequity.</p>